These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder.
    Author: Chrapko WE, Jurasz P, Radomski MW, Lara N, Archer SL, Le Mellédo JM.
    Journal: Biol Psychiatry; 2004 Jul 15; 56(2):129-34. PubMed ID: 15231445.
    Abstract:
    BACKGROUND: Major depression (MD) has been associated with increased cardiovascular mortality in patients with coronary heart disease (CHD) and has been described as an independent risk factor for the development of CHD in healthy subjects; however, the mechanism of the association between MD and CHD remains to be determined. Nitric oxide (NO) plays a major role in cardiovascular regulation, and decreased NO production has been associated with several cardiovascular risk factors. We hypothesized that in patients with MD, NO production by both platelets and the endothelium would be reduced when compared with healthy control subjects (HCs). METHODS: Blood samples were obtained from 15 subjects with MD and 16 HCs with no known history of cardiovascular illness. Plasma NO metabolite (NOx) levels were analyzed by chemiluminescence. Platelet endothelial NO synthase (eNOS) activity was examined through the conversion of l-[(14)C]arginine to l-[(14)C]citrulline. RESULTS: The levels of both plasma NOx and platelet eNOS activity were significantly lower in subjects with MD compared with HCs. CONCLUSIONS: These data suggest that decreased NO production by the vascular wall and platelets might contribute to the increased CHD risk observed in patients with MD.
    [Abstract] [Full Text] [Related] [New Search]